Where is industry getting it wrong? A review of quality concerns raised during Marketing Authorisation submissions - 17/8/09
Medicines Authority Circular No P09/2008 Re: Requirements for submission of E2B(M) Individual Case Safety Reports (ICSRs) to the Medicines Authority - 04.07.2008
PLU01/2006 Report on the European Commission Assessment of the Community System of Pharmacovigilance
DH Circular 97/06 - Update on registration on medicinal products for human use
DH Circular No 138/05 - Update on Medicinal Products for Human Use
Commission Guideline on Braille requirements for labelling and package leaflet.
DH Circular No 70/05
Fees (L.N. 315/2006)
Fees in Euros
Letter of access to be signed by Marketing Authorisation Holders giving access to local licensed wholesale dealers (pharmaceuticals) to use the Marketing Authorisation issued by the Medicines Authority to place a medicinal product on the market in Malta
Guidance note regarding Medicinal Product Defect Reporting
Medicinal Product Defect Reporting Form
Communication regarding the Transition List for Traditional Herbal Medicinal Products
Diclogesic 12.5mg Suppositories (Class II Medicines Recall) Amsidine 75mg ampoules, solution for infusion (Class 2 Medicines Recall) Qualified Person (QP) Eligibility Interviews 4th-7th May 2004 Application for a wholesale dealer's licence for medicinal products for human use Application for an import licence for medicinal products for human use - 18/01/2006
Application for a Manufacturers Licence for Medicinal products for Human Use - 18/01/2006
Application for a Certificate of a Pharmaceutical Product
Information for Wholesale Dealers/Distributors Regarding the Regulation of Traditional Herbal Medicinal Products
Pre-Licensing (Marketing Authorisations)
Post-Licensing
Inspectorate (Manufacturing, Importer and Wholesaler licensing)
Linguistic Check Process (QRD)
Advertising
Legislation
Old Circulars
| Licensing | Marketing Authorisations | Parallel Importation | Clinical Trials | Herbal Medicinal Products | Homeopathic Products | Borderline Classification Committee | Post-Licensing | Advertising | Scientific Advice | Inspectorate | | Regulatory Affairs | EU Legislation | Maltese Legislation | Information | Publications | News & Events | Contact Us | Links | Help |
| Disclaimer | Copyright | Privacy Policy | Feedback Form | DOI | gov.mt | Search | Office of the Prime Minister |
The content has been collated by staff of the Medicines Authority. Please if you require other information that is not on these pages. We will do our best to help you.